Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0311391002
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Approved | 02277816 | TANTA PHARMACEUTICALS INC | ACETAMINOPHEN 300MG, CAFFEINE & CODEINE | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled (Unreturned Annual) | 02229962 | TECHNILAB PHARMA INC. | ACETAMINOPHEN 325 C & C | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 325 MG |
| Approved | 02271834 | TANTA PHARMACEUTICALS INC | ACETAMINOPHEN 325 MG CAFFEINE AND CODEINE | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 325 MG |
| Cancelled Post Market | 00706221 | VITA HEALTH PRODUCTS INC | ACETAMINOPHEN 325 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 325 MG |
| Cancelled Post Market | 01997688 | NOVOPHARM LIMITED | ACETAMINOPHEN CAFFEINE & 8MG COD. PHOS. TAB | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled Post Market | 00599131 | D.C. LABS LIMITED | ACETAMINOPHEN COMPOUND TABLETS WITH CODEINE 8MG | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Marketed | 02143933 | TEVA CANADA LIMITED | ACETAMINOPHEN WITH CODEINE - CAPLET | Human | Yes | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled Post Market | 02237420 | PHARMASCIENCE INC | ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Dormant | 02246085 | JAMP PHARMA CORPORATION | ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE TABLETS | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled Post Market | 02025337 | PHARMASCIENCE INC | ACETAMINOPHEN, CAFFEINE & CODEINE | Human | No | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 8 MG |
| Cancelled Post Market | 02028174 | PHARMASCIENCE INC | ACETAMINOPHEN, CAFFEINE & CODEINE | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled Pre Market | 02387255 | PHARMASCIENCE INC | ACETAMINOPHEN, CAFFEINE & CODEINE TABLETS | Human | No | Narcotic (CDSA I) | 3 | CODEINE PHOSPHATE | 8 MG |
| Dormant | 02248817 | CELLCHEM PHARMACEUTICALS INC. | ACETAMINOPHEN, CAFFEINE AND 8 MG OF CODEINE PHOSPHATE TABLETS | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 325 MG |
| Marketed | 02154234 | LABORATOIRE RIVA INC. | ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Dormant | 02251914 | CELLCHEM PHARMACEUTICALS INC. | ACETAMINOPHEN, CAFFEINE, AND 8MG OF CODEINE PHOSPHATE TABLETS | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled Pre Market | 02254700 | LABORATOIRES CONFAB INC | ACETAMINOPHEN-CAFFEINE-CODEINE | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Approved | 02265052 | APOTEX INC | APO-ACETACO #1 | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled Post Market | 00615528 | NOVOPHARM LIMITED | NOVO-GESIC-C8 | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled (Unreturned Annual) | 02336472 | NU-PHARM INC | NU-ACETACO #1 | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Marketed | 00653233 | TEVA CANADA LIMITED | TEVA-LENOLTEC NO. 1 | Human | Yes | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Dormant | 00852163 | LABORATOIRE RIVA INC. | TRIATEC-8 | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 325 MG |
| Cancelled Post Market | 00425362 | MCNEIL PHARMACEUTICAL, DIVISION OF ORTHO-MCNEIL INC. | TYLENOL NO 1 TAB | Human | No | Narcotic | 3 | ACETAMINOPHEN | 300 MG |
| Cancelled Post Market | 02181061 | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | TYLENOL NO.1 CAPLETS | Human | Yes | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
| Dormant | 02453703 | JAMP PHARMA CORPORATION | WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE | Human | No | Narcotic (CDSA I) | 3 | ACETAMINOPHEN | 300 MG |
Application information
Related information
Contact us
Version 4.0.2